An original finding of our study was the association of HO-1 with HMGB1 levels, suggesting that targeting the HO-1/HMGB1 relationship may provide a new line of support against the transition from mild/moderate to severe COVID-19 development. This evidence concerns the gene HMGB1 and COVID-19.